Patent ID: 11959144
Assignee: NATIONAL CANCER CENTER
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 0:
1. A method for detecting prostate cancer in a human subject, comprising:
measuring an expression level of hsa-miR-6741-5p in a blood, serum, or plasma sample from the subject;
comparing the measured expression level of hsa-miR-6741-5p to a control expression level in a sample from a healthy subject;
detecting a decreased level of hsa-miR-6741-5p in the sample from the subject as compared to the control expression level from the sample from the healthy subject;
wherein the decreased level of hsa-miR-6741-5p indicates that the subject has prostate cancer; and
wherein the method further comprises treating the subject for the prostate cancer or performing a diagnostic procedure on the subject with the prostate cancer;
wherein the treating comprises surgery, radiotherapy, chemotherapy or the combination thereof, and
wherein the diagnostic procedure comprises rectal examination, transrectal ultrasonography of the prostate, or imaging of prostate tissue.